BIOVERATIV INC. SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction
BIOVERATIV INC. reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction of $459.40 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-14.
Discontinued › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesDeductions · last filed 2018-02-14
- BIOVERATIV INC. sec schedule, 12-09, valuation allowances and reserves, deduction for the quarter ending 2017-12-31 was $125.40M.
- BIOVERATIV INC. sec schedule, 12-09, valuation allowances and reserves, deduction for the quarter ending 2017-09-30 was $118.30M.
- BIOVERATIV INC. sec schedule, 12-09, valuation allowances and reserves, deduction for the quarter ending 2017-06-30 was $111.60M.
- BIOVERATIV INC. sec schedule, 12-09, valuation allowances and reserves, deduction for the quarter ending 2017-03-31 was $104.10M.
- BIOVERATIV INC. sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2017 was $459.40M, a 46.45% increase from fiscal 2016.
- BIOVERATIV INC. sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2016 was $313.70M.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction 3 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction 6 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction 9 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction 12 month |
|---|---|---|---|---|
| 2017-12-31 | $125.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $243.70M derived: sum of 2 quarters · filed 2018-02-14 | $355.30M derived: sum of 3 quarters · filed 2018-02-14 | $459.40M 10-K · filed 2018-02-14 |
| 2017-09-30 | $118.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $229.90M derived: sum of 2 quarters · filed 2017-10-27 | $334.00M 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $111.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $215.70M 10-Q · filed 2017-08-03 | ||
| 2017-03-31 | $104.10M 10-Q · filed 2017-05-12 | |||
| 2016-12-31 | $313.70M 10-K · filed 2018-02-14 |